Refreshing results…
High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer
Download from doi.orgIn the Literature: January 2023
UploadImmunological Landscape of HER-2 Positive Breast Cancer
Download from doi.orgTargeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer
Download from doi.orgmTOR Inhibition and T-DM1 in HER2-Positive Breast Cancer
UploadIn the literature: August 2021
UploadMissing publications? Search for publications with a matching author name.